Enhancing risk stratification for life-threatening ventricular arrhythmias in dilated cardiomyopathy: the peril and promise of precision medicine
ESC Heart Fail
.
2020 Aug;7(4):1383-1386.
doi: 10.1002/ehf2.12886.
Epub 2020 Jul 9.
Authors
Babken Asatryan
1
,
C Anwar A Chahal
2
3
4
Affiliations
1
Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
2
Division of Cardiology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
3
Department of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
4
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
PMID:
32643283
PMCID:
PMC7373937
DOI:
10.1002/ehf2.12886
No abstract available
Publication types
Editorial
Comment
MeSH terms
Arrhythmias, Cardiac / therapy
Cardiomyopathy, Dilated* / complications
Death, Sudden, Cardiac
Humans
Precision Medicine
Risk Assessment